Project Grant R21AA031654
- This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under CFDA 93.273 - Alcohol Research Programs, will fund a longitudinal study on alcohol consumption, contexts, and consequences across the transition to legal drinking age in the United States. The University of Missouri System will receive $719,749 to conduct this 5-year study, starting on September 10, 2025. The researchers will use ecological momentary assessment (EMA) to collect self-report,...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), provides $1,178,880.00 in funding to the University of Washington for a 5-year study titled "Modeling Weekly and Daily Processes of a High-Risk Feedback Cycle of Alcohol, Cannabis, and Nonmedical Use of Prescription Stimulants in College Students: Impacts on Use, Academics, and Sleep." The project aims to investigate the mechanisms behind the...
- This $1,039,420 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to study the neuronal ensembles and circuits involved in the facilitation and disinhibition of opioid and alcohol seeking behaviors. The 5-year project, which begins on June 1, 2025 and runs through February 28, 2030, will employ innovative techniques such as single-nucleus RNA sequencing, spatial sequencing, and in vivo...
- This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) program, supports a $559,180 research project to investigate neurobiological factors underlying Alcohol Use Disorder (AUD) with and without comorbid cigarette smoking. The project aims to identify AUD-associated differences in DNA methylation and RNA expression in the nucleus accumbens and dorsolateral prefrontal cortex, key brain regions...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $498,002 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Illinois to conduct a study aimed at increasing alcohol abstinence in young adults with alcohol use disorder (AUD). The overall goals of this 3-year project are to: (1) test the efficacy of combining contingency management (CM) with problem-solving therapy (CM-PST) versus CM alone in a 2-arm pilot randomized controlled trial, and...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) provides $248,999 to Virginia Commonwealth University to explore the genetic and neurocognitive mechanisms underlying the co-occurrence of alcohol use/problems and suicidal thoughts and behaviors. The overarching goal is to examine how aggregate genetic liability and decision-making processes may contribute to this co-occurrence. The 3-year project period runs from...
- This $232,316 Project Grant awarded by the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) supports research to investigate the role of a novel dynorphinergic circuit in the central amygdala and its connection to the nucleus accumbens. The research aims to understand how this circuit is modulated by chronic pain and fentanyl abstinence, and how it contributes to binge-like alcohol drinking behavior, pain-related cognitive effects, and reinstatement of...
- This $587,361 federal Project Grant awarded by the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) to the University of Colorado-Denver will fund a 5-year research project to investigate the relationship between pain, negative affect, and alcohol use. The project will combine laboratory-based pain induction and ecological momentary assessment (daily text-message surveys) to examine pathways from pain to alcohol use, as well as factors like pain...
- This $1,672,696 project grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to identify the computational and neurophysiological mechanisms underlying the interplay between craving and decision-making in cannabis use disorders. The project will deploy a paradigm to assess craving and decision-making across two independent samples of cannabis users (online: n=1,000; in-person: n=100) and implement a joint modeling...
This $407,812 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 Alcohol Research Programs) will fund a study by the University of Oregon examining the dynamic associations between impulsivity, craving, and co-use of alcohol, cannabis, and nicotine among young adults. The study aims to collect intensive longitudinal data from 250 young adults to investigate how impulsiveness and craving vary between and within different substance use episodes, with a focus on understanding the additive effects of cannabis and/or nicotine use on the relationship between impulsivity and craving relative to alcohol-only occasions. The project will utilize a complementary set of intensive longitudinal analytic methods to contrast levels of impulsivity and craving across alcohol-only, dual-use, and tri-use episodes, as well as examine the role of cannabis and nicotine on these factors over the course of an alcohol use occasion. The study has a project period from September 10, 2025 to August 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $407.8k | 9/9/25 |